NEW ORLEANS-(BUSINESS WIRE)-Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Prometheus Biosciences, Inc. (NasdaqGS: RXDX) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Prometheus will receive $200.00 in...
Prometheus Biosciences is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of immune-mediated diseases.